Large Molecule Bioanalytical Technologies Market Size – By Offering (Products, Service), Technology (ELISA, Chromatography, Flow Cytometry), Application (Biologics, Viral Vector), End-use (Pharmaceutical & Biotechnology Companies) & Forecast, 2024 - 2032

Large Molecule Bioanalytical Technologies Market Size

Large Molecule Bioanalytical Technologies Market size was valued at USD 8.3 billion in 2023 and is estimated to expand at over 10.4% CAGR from 2024 to 2032. Large molecule bioanalytical technologies refer to a set of analytical techniques and methodologies used to study and characterize large biological molecules such as proteins, peptides, nucleic acids (DNA, RNA), antibodies, and other biologics. These technologies are essential for understanding the structure, function, interaction, and quantity of these molecules in biological systems. 
 

The increasing prevalence of chronic diseases is a significant driver for the large molecule bioanalytical technologies market. For instance, according to the International Diabetic Federation (IDF), in 2021, approximately 537 million adults lived with diabetes worldwide, with predictions suggesting that this figure will reach 643 million by 2030. Therefore, large molecule bioanalytical technologies are required for accurate diagnosis, monitoring, drug development, biomarker discovery, and personalized treatment strategies.
 

Furthermore, increasing demand for biologics & biosimilars, rising advancements in bioanalytical technology, increasing research and development in the multi-omics sector, which is set to reach 12.2 billion by 2032, increasing drug development and clinical trials, rising adoption of biomarkers-based diagnostics, are the contributing factors stimulating the growth of the market.
 

Large Molecule Bioanalytical Technologies Market Trends

Rising advancements in bioanalytical technology play a pivotal role in large molecule bioanalytical technologies industry as they drive innovation, improves analytical capabilities, and expand the scope of applications.

• Advancements in chromatography instruments, electrophoresis, and western blot techniques have resulted in improved resolution, enabling the separation and analysis of complex mixtures of large molecules with higher accuracy and precision.
   
• For instance, novel high pressure liquid chromatography (HPLC) column advancements such as sub-2 micro particles, core-shell particles, and hybrid particles have emerged, enhancing pharmaceutical analysis.
   
• Furthermore, technological innovations have led to the development of more sensitive detection methods techniques such as mass spectrometry, and flow cytometry. As, increased sensitivity allows for the detection and quantification of low-abundance biomolecules, facilitating the study of rare proteins, metabolites, and nucleic acids.
   

Large Molecule Bioanalytical Technologies Market Analysis

Based on offering, the market is bifurcated into products and service. The products segment is poised to surpass USD 14.2 billion by the end of 2032.
 

• Products serve as indispensable tools in large molecule bioanalytical technologies, enabling researchers to analyze, quantify, and characterize biomolecules with precision and efficiency.
   
• Furthermore, products provide accurate and specific identification of biomolecules, minimizing false positives and ensuring reliable results.
   
• Additionally, they offer versatile tools and technologies for the comprehensive analysis of proteins, peptides, nucleic acids, and carbohydrates across a wide range of biological samples and applications. As, they play a critical role in advancing our understanding of biological systems, disease mechanisms, and therapeutic interventions.
   

Based on technology, the large molecule bioanalytical technologies market is segmented into chromatography, mass spectrometry, ELISA, electrophoresis, polymerase chain reaction, western blot, flow cytometry, spectrometer, and other technologies. The chromatography segment held over USD 2.1 billion revenue in 2023.
 

• Chromatography provides high-resolution separation of complex mixtures of large biomolecules, allowing for the detection and quantification of individual components with precision.
   
• Furthermore, different techniques such as liquid chromatography, gas chromatography, and paper chromatography offer versatility in separating various types of biomolecules including proteins, peptides, nucleic acids, and carbohydrates.
   
• Chromatography systems can be automated to handle large sample volumes and process multiple samples in parallel, increasing throughput and efficiency. As, this is essential for high-throughput screening and biomarker discovery, and thereby propelling the segmental growth of the market.
   

Based on application, the large molecule bioanalytical technologies market is classified into biologics, oligonucleotide derived drugs & molecules, viral vector, cell & gene therapy, nanoparticles & polymers, disease diagnosis, and other applications. The biologics segment is estimated to reach USD 6.1 billion by the end of 2032.
 

• Biologics, exemplified by monoclonal antibodies and recombinant proteins, are engineered to selectively target specific biomolecules with exceptional affinity. This targeted specificity empowers accurate identification, measurement, and manipulation of desired molecules within intricate biological samples.
   
• Furthermore, compared to small molecule drugs, biologics generally have lower immunogenicity, reducing the risk of adverse immune reactions in patients. As, this enhances their safety profile and allows for repeated administration in therapeutic and diagnostic applications.
   
• Moreover, biologics often exhibit favorable pharmacokinetic properties, such as longer half-lives and reduced clearance rates, compared to small molecule drugs. These properties can result in prolonged therapeutic effects, less frequent dosing regimens, and enhancing patient compliance & convenience. Thus, stimulating the segmental growth.
   

Based on end-use, the large molecule bioanalytical technologies market is segmented into pharmaceutical & biotechnology companies, contract research organizations, research & academic institutes, and other end-users. The pharmaceutical & biotechnology companies segment accounted for 45.9% of the market share in 2023.
 

• Pharmaceutical & biotechnology companies are at the forefront of developing biologics, cell & gene therapeutics, and nanoparticles & polymers. As, these large molecules require advanced bioanalytical technologies for characterization, quality control, and regulatory approval.
   
• Large molecule bioanalysis is crucial in all stages of clinical trials. As, these companies conduct the trials and rely on bioanalytical tools for data generation and interpretation. Consequently, increasing the adoption of these technologies.
   
• Additionally, these companies diversify their portfolios with a range of diagnostic, and therapeutic products, targeting different areas of human health. Each of these products requires tailored bioanalytical methods, leading to investment in a variety of technologies, thereby bolstering the segmental growth of the market.
   

North America large molecule bioanalytical technologies market size recorded around USD 3.4 billion in 2023.
 

• The region has a robust infrastructure for technology development and adoption. This includes advanced laboratories, research centers, and academic institutions focused on bioanalytical technologies.
   
• Further, the competitive landscape in North America fosters innovation among bioanalytical technology companies. This results in a continuous stream of new and advanced products entering the market. As, collaborations between academic research institutions and industry players further drive innovation in bioanalytical technologies.
   
• Additionally, the region attracts top talent in the fields of biotechnology, biochemistry, and molecular biology, offering a skilled workforce capable of driving advancements in bioanalytical tools and technologies, thus stimulating the growth of the market.
   

Large Molecule Bioanalytical Technologies Market Share

The large molecule bioanalytical technologies industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Charles River Laboratories International, Inc, Halo Labs Inc., Danaher Corporation among others have a notable presence in the market.
 

Large Molecule Bioanalytical Technologies Market Companies

Some of the eminent market participants operating in the large molecule bioanalytical technologies industry include:

• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• Cergentis B.V.
• Charles River Laboratories International, Inc.
• Danaher Corporation
• Halo Labs, Inc
• Intertek Group plc
• Laboratory Corporation of America Holdings
• Shizmandu Corporation
• SOLVIAS AG
   

Large Molecule Bioanalytical Technologies Industry News

• In November 2023, Halo Labs Inc, introduced a new consumable plate. This plate catered to large molecule drug developers seeking to count, size, image, and identify particles within highly concentrated and viscous solutions. Thus, this product launch broadened the company’s offerings and potentially increased its market share in the field of bioanalysis sector.
   
• In March 2021, Charles River Laboratories International, Inc. announced the acquisition of Retrogenix Limited, an early-stage contract research organization (CRO) that provided specialized bioanalytical services utilizing its proprietary cell microarray technology. This acquisition aided the company by enhancing its capabilities in large molecule bioanalytical technologies and further increased the sales & revenue.
   

The large molecule bioanalytical technologies market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Offering

• Products
  • Consumables & accessories
  • Instruments
  • Reagents & kits
• Service

Market, By Technology

• Chromatography
• Mass spectrometry
• ELISA
• Electrophoresis
• Polymerase chain reaction
• Western blot
• Flow cytometry
• Spectrometer
• Other technologies

Market, By Application

• Biologics
• Oligonucleotide derived drugs & molecules
• Viral vector
• Cell & gene therapy
• Nanoparticles & polymers
• Disease diagnosis
• Other applications

Market, By End-use

• Pharmaceutical & biotechnology companies
• Contract research organizations
• Research & academic institutes
• Other end-users

The above information has been provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa